Cargando…

Evaluation and management of platelet transfusion refractoriness

Platelet transfusion refractoriness (PTR), in which platelet counts do not increase after transfusion, occurs in many patients receiving platelet transfusions. PTR is a clinical condition that can harm patients. The causes of PTR can be divided into two types: immune and non-immune. Most cases of PT...

Descripción completa

Detalles Bibliográficos
Autores principales:	Youk, Hee-Jeong, Hwang, Sang-Hyun, Oh, Heung-Bum, Ko, Dae-Hyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9057673/ https://www.ncbi.nlm.nih.gov/pubmed/35483919 http://dx.doi.org/10.5045/br.2022.2021229

Ejemplares similares

Transfusion thresholds: the need for a patient-centered approach in hematologic disorders that require chronic transfusion therapy
por: Kim, Han Joo, et al.
Publicado: (2023)

Clinical Significance of Hemagglutination Grades Determined Using the IH-1000 Automated Blood Typing Instrument: Real-world Data
por: Park, Bosung, et al.
Publicado: (2022)

A New Trial to Measure ABO Antibodies Using Complement-Dependent Cytotoxicity
por: Youk, Hee-Jeong, et al.
Publicado: (2022)

Related donor platelet transfusion improves platelet transfusion refractoriness in hematological patients
por: Zhang, Jing-Cheng, et al.
Publicado: (2023)

Refractoriness to platelet transfusion after single-donor consecutive platelet transfusions and its relationship to platelet antibodies.
por: Lee, M., et al.
Publicado: (1988)

Prevalence of platelet reactive antibodies in patient's refractory to platelet transfusions
por: Agarwal, Nitin, et al.
Publicado: (2014)

Nanoparticle-Based Visual Detection of Amplified DNA for Diagnosis of Hepatitis C Virus
por: Kim, Soo-Kyung, et al.
Publicado: (2022)

Non-Alloimmune Mechanisms of Thrombocytopenia and Refractoriness to Platelet Transfusion
por: Belizaire, Roger, et al.
Publicado: (2020)

Investigation of variables affecting the immunogenicity of blood group antigens using a calculation formula
por: Chung, Yousun, et al.
Publicado: (2023)

Evaluation of Human Leucocyte Antigen Mediated Platelet Transfusion Refractoriness and Platelet Crossmatching Assay in Patients with Hematologic Disorders
por: Neanaey, Wafaa A., et al.
Publicado: (2022)

Extent of transfusion support in a developing country in managing a bleeding acute myeloid leukemia patient with platelet transfusion refractoriness
por: Chellaiya, Gayathiri K., et al.
Publicado: (2021)

Current concepts in platelet transfusion
por: Mohanty, Dipika
Publicado: (2009)

Microparticle-tagged image-based cell counting (ImmunoSpin) for CD4 + T cells
por: Hwang, Sang-Hyun, et al.
Publicado: (2021)

Platelet Transfusion: And Update on Challenges and Outcomes
por: Solves Alcaina, Pilar
Publicado: (2020)

The Use of Splenectomy to Manage Platelet Transfusion Refractoriness due to Anti-Human Leukocyte Antibodies in Allogeneic Stem Cell Transplantation
por: Mauro, Margherita, et al.
Publicado: (2016)

Platelets: Production, Function, Transfusion, and Storage
por: Marchesi, Sally L.
Publicado: (1975)

Platelet transfusion for cancer secondary thrombocytopenia: Platelet and cancer cell interaction
por: Wang, Juan, et al.
Publicado: (2021)

Bacterial contamination of platelets for transfusion: strategies for prevention
por: Levy, Jerrold H., et al.
Publicado: (2018)

Changes in inflammatory responses and autophagy during apheresis platelet preservation and their correlation with platelet transfusion refractoriness in patients with acute lymphoblastic leukemia
por: Li, Ying, et al.
Publicado: (2023)

Platelet transfusions: trigger, dose, benefits, and risks
por: Blumberg, Neil, et al.
Publicado: (2010)

First platelet transfusion refractoriness in a patient with acute myelocytic leukemia: A case report
por: Tu, Sheng-Ke, et al.
Publicado: (2023)

A case of platelet transfusion refractoriness in a CD36‐negative patient with acute myeloid leukemia: Diagnostic and therapeutic management
por: Pedini, Pascal, et al.
Publicado: (2022)

Successful management of severe allergic reactions to platelet transfusion with omalizumab: A case report
por: Choi, Yeonjoo, et al.
Publicado: (2021)

The Signaling Role of CD40 Ligand in Platelet Biology and in Platelet Component Transfusion
por: Aoui, Chaker, et al.
Publicado: (2014)

The First Case of Para-Bombay Blood Type Encountered in a Korean Tertiary Hospital
por: Kim, Min-Sun, et al.
Publicado: (2019)

Prediction of Mid-term Platelet Transfusion in Stable Trauma Patients Using Rotational Thromboelastometry
por: Lim, Ha Jin, et al.
Publicado: (2024)

Neonatal thrombocytopenia and platelets transfusion
por: Gupta, Anil K., et al.
Publicado: (2012)

PB2596: OPTIMIZING PLATELET TRANSFUSION FOR CLINICAL PRACTICE. DO PLATELETS AGE MATTER FOR THERAPEUTIC PLATELETS TRANSFUSION?
por: Attallah, Samy, et al.
Publicado: (2023)

Redox Proteomics and Platelet Activation: Understanding the Redox Proteome to Improve Platelet Quality for Transfusion
por: Sonego, Giona, et al.
Publicado: (2017)

Risk-Reduction Strategies for Platelet Transfusion in the United States
por: Vamvakas, Eleftherios C.
Publicado: (2011)

Current Status of and Global Trends in Platelet Transfusion Refractoriness From 2004 to 2021: A Bibliometric Analysis
por: Liu, Ying, et al.
Publicado: (2022)

Clinical and immunological features of platelet transfusion refractoriness in young patients with de novo acute myeloid leukemia
por: Hu, Xuelian, et al.
Publicado: (2020)

Anti-HLA Class I alloantibodies in platelet transfusion refractoriness: From mechanisms and determinants to therapeutic prospects
por: Couvidou, Adèle, et al.
Publicado: (2023)

Prevalence, Risk Factors, and Outcomes of Platelet Transfusion Refractoriness in Critically Ill Patients: A Retrospective Cohort Study
por: Arabi, Saeed, et al.
Publicado: (2021)

Transfusion practice in neonates
por: Kim, Do-Hyun
Publicado: (2018)

Immunological Features in the Process of Blood Platelet-Induced Alloimmunisation, with a Focus on Platelet Component Transfusion
por: Garraud, Olivier, et al.
Publicado: (2019)

Platelet Transfusion—Insights from Current Practice to Future Development
por: Capraru, Annina, et al.
Publicado: (2021)

Cytokine Release Syndrome Is an Independent Risk Factor Associated With Platelet Transfusion Refractoriness After CAR-T Therapy for Relapsed/Refractory Acute Lymphoblastic Leukemia
por: Liu, Yadan, et al.
Publicado: (2021)

Identification of 8-Digit HLA-A, -B, -C, and -DRB1 Allele and Haplotype Frequencies in Koreans Using the One Lambda AllType Next-Generation Sequencing Kit
por: Choe, Wonho, et al.
Publicado: (2021)

Transfusion‐induced platelet antibodies and regulatory T cells in multiply transfused patients
por: Song, Tiejun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gbbs3sneicosoj2kj43b5kdf32